Quantum computers are recently being developed in wide varieties, but the computational results from quantum computing have been largely confined to constructing artificial assignments. The applications of quantum computers to real-world problems are still an active area of research. However, challenges arise when the limits of scale and complexity in biological problems are pushed, which has affected drug discovery. The fast-evolving quantum computing technology has transformed the computational capabilities in drug research by searching for solutions for complicated and tedious calculations. Quantum computing (QC) is exponentially more efficient in drug discovery, treatment, and therapeutics, generating profitable business for the pharmaceutical industry. In principle, it can be stated that quantum computing can solve complex problems exponentially faster than classical computing. Here it is needed to mention that QC will not be able to take on every task that classical computers perform—at least not now. It may be classical and quantum-coupled computational technologies combined with machine learning (ML) and artificial intelligence (AI) will solve each task in the future. This review is an overview of quantum computing, which may soon revolutionize the pharmaceutical industry in drug discovery.
Quantum computers are recently being developed in wide varieties, but the computational results from quantum computing have been largely confined to constructing artificial assignments. The applications of quantum computers to real-world problems are still an active area of research. However, challenges arise when the limits of scale and complexity in biological problems are pushed, which has affected drug discovery. The fast-evolving quantum computing technology has transformed the computational capabilities in drug research by searching for solutions for complicated and tedious calculations. Quantum computing (QC) is exponentially more efficient in drug discovery, treatment, and therapeutics, generating profitable business for the pharmaceutical industry. In principle, it can be stated that quantum computing can solve complex problems exponentially faster than classical computing. Here it is needed to mention that QC will not be able to take on every task that classical computers perform—at least not now. It may be classical and quantum-coupled computational technologies combined with machine learning (ML) and artificial intelligence (AI) will solve each task in the future. This review is an overview of quantum computing, which may soon revolutionize the pharmaceutical industry in drug discovery.
Quantum computers are recently being developed in wide varieties, but the computational results from quantum computing have been largely confined to constructing artificial assignments. The applications of quantum computers to real-world problems are still an active area of research. However, challenges arise when the limits of scale and complexity in biological problems are pushed, which has affected drug discovery. The fast-evolving quantum computing technology has transformed the computational capabilities in drug research by searching for solutions for complicated and tedious calculations. Quantum computing (QC) is exponentially more efficient in drug discovery, treatment, and therapeutics, generating profitable business for the pharmaceutical industry. In principle, it can be stated that quantum computing can solve complex problems exponentially faster than classical computing. Here it is needed to mention that QC will not be able to take on every task that classical computers perform—at least not now. It may be classical and quantum-coupled computational technologies combined with machine learning (ML) and artificial intelligence (AI) will solve each task in the future. This review is an overview of quantum computing, which may soon revolutionize the pharmaceutical industry in drug discovery.
It is widely accepted that quantum computation and the science of quantum computation mechanics are excellent tools for drug design and discovery because of their high precision in estimating numerous relevant parameters. A scientist can use quantum computing to perform hundreds of millions of comparisons of complex molecules at the same time to examine matches between the molecules, and both the positive and negative effects of a new therapeutic approach can be predicted. These approaches make the most significant contribution to the development of drugs in clinical use or clinical trials. These methods emerge and develop in tandem with the experimental approaches used in drug design. Quantum Computational (QC) methods offer a highly precise description of protein–ligand interactions. This method defines nuclei and electron behavior and explains molecular interactions in terms of distribution and motion. Quantum computers have the potential to revolutionize computation by solving previously intractable problems. Quantum computers are extremely fast and efficient. They can perform calculations that would take decades or even millennia on today's supercomputers in a matter of seconds. Experts refer to this fact as quantum superiority over other traditional methods. Second, QCs can also be archetypal complicated structures that will allow researchers to understand the interaction of both small molecules and biologics before the preclinical and clinical stages of drug development. In practice, quantum computational methods will not be able to take over every task performed by classical computational methods—at least not anytime soon. However, in the future, these methods may be combined with traditional computational technologies such as machine learning (ML) and artificial intelligence (AI) to pave a new and groundbreaking path toward the goal of drug discovery and development.
The integration of quantum computing in drug discovery has the potential to revolutionize pharmaceutical research by significantly enhancing molecular simulations, drug screening, and optimization processes. Traditional computational methods often struggle with the complexity of molecular interactions, leading to high costs and extended timelines in drug development. Quantum computing, with its ability to process complex calculations exponentially faster than classical computers, offers innovative solutions to these challenges. This chapter explores the fundamentals of quantum computing, its application in pharmaceutical research, and real-world case studies from leading organizations. It also discusses existing challenges, potential solutions, and future directions for adopting quantum computing in drug discovery. By addressing key technical, ethical, and regulatory aspects, this chapter provides a comprehensive analysis of how quantum technologies can accelerate and optimize the drug discovery pipeline.
The integration of quantum computing and artificial intelligence (AI), collectively termed Quantum AI, is revolutionizing the pharmaceutical industry by reshaping the paradigms of drug discovery and development. Traditional approaches to drug design are often limited by high costs, extensive timelines, and the computational intractability of simulating complex molecular interactions. Quantum computing offers exponential processing power, enabling the accurate modeling of quantum-level chemical phenomena that classical computers struggle to handle. Concurrently, AI contributes by enhancing data interpretation, prediction of molecular behaviors, and pattern recognition across large biological datasets. Together, Quantum AI enables faster identification of drug candidates, improved simulation of drug-target interactions, and early prediction of pharmacokinetics and toxicity. Key quantum algorithms, such as the Variational Quantum Eigensolver (VQE) and quantum-enhanced machine learning, have demonstrated potential to outperform conventional methods in quantum chemical calculations. Moreover, this synergy facilitates personalized medicine by integrating patient-specific data to optimize therapeutic outcomes. Despite current challenges related to hardware scalability, algorithm optimization, and ethical integration, the future trajectory of Quantum AI is poised to redefine pharmaceutical innovation. This review underscores the transformative capabilities of Quantum AI and its potential to usher in a new era of efficient, cost-effective, and precision-driven drug development.
The pharmaceutical industry relies heavily on the drug discovery process to develop new medications that can help treat various diseases. This process is highly crucial but also very time-consuming, as it involves screening a massive number of chemical compounds to identify those that can be developed into effective treatments. Traditional computing methods are often inadequate for this task due to the complexity and vastness of the data involved. Quantum computing is an emerging field that has gained significant attention in recent years due to its ability to perform complex computations at a much faster pace than classical computers. Quantum computing uses the principles of quantum mechanics, which differ significantly from classical computing. Drug discovery involves a process of identifying new drugs with the desired biological activity to treat specific diseases. This process can be quite lengthy, time-consuming, and expensive, often taking many years to develop a single drug. However, quantum computing has the potential to revolutionize the drug discovery process. Its ability to perform complex calculations quickly and efficiently could significantly speed up the drug discovery process, making it more cost-effective and accurate. Quantum computing's potential in drug discovery requires further research to fully understand and develop practical applications. The use of quantum computing requires the development of specialized algorithms and software tailored to quantum computing. Further investment in research and development is needed to fully leverage the potential of this technology. This paper explores the potential of quantum computing in drug discovery. We will analyze the benefits of using quantum computing in drug discovery, including faster and more accurate data processing, improved optimization, and more efficient screening of chemical compounds. Our paper will also discuss the challenges and limitations that need to be addressed to fully leverage the potential of quantum computing in drug discovery. This will include discussing potential applications of quantum computing in drug discovery, as well as the need for further investment in research and development to fully realize the potential of this technology. Overall, our paper will provide a comprehensive analysis of the potential of quantum computing in drug discovery, exploring both the benefits and challenges associated with this technology and providing recommendations for future research and development.
Quantum AI, the integration of quantum computing and artificial intelligence, is revolutionizing drug design by addressing the limitations of traditional pharmaceutical development. This review explores its transformative potential in enhancing molecular simulations, structure-based, target-based, and ligand-based drug discovery, and personalized medicine. Quantum computing leverages principles like superposition, entanglement, and interference to perform complex calculations exponentially faster than classical systems, enabling precise modeling of molecular interactions. Algorithms such as the Variational Quantum Eigensolver (VQE) and Quantum Phase Estimation (QPE) outperform classical methods like Density Functional Theory (DFT) in accuracy and efficiency, facilitating the identification of promising drug candidates and optimizing their pharmacokinetic properties. Quantum AI also enhances personalized medicine by analyzing vast genomic datasets to tailor treatments, improving efficacy and minimizing adverse effects. Despite challenges, including noisy intermediate-scale quantum (NISQ) device limitations and the need for advanced error correction, ongoing research and interdisciplinary collaboration are driving progress. Quantum AI promises to reduce development costs, accelerate drug discovery, and democratize access to life-saving medications. By enabling simulation-based discovery and expanding drug-candidate libraries to include peptides and antibodies, it paves the way for breakthroughs in treating complex diseases. This review underscores the need for continued investment in quantum technology to fully harness its potential, positioning the pharmaceutical industry for a future where drug development is faster, more precise, and patient-centric, ultimately improving global healthcare outcomes.